Madhavan Balachandran Amgen Inc (AMGN) insider trading activity

Madhavan Balachandran is EVP, Operations of AMGEN INC. Currently has a direct ownership of 23,097 shares of AMGN, which is worth approximately $6.47 Million. The most recent transaction as insider was on May 03, 2016, when has been sold 3,581 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.1K

0% 3M change

0% 12M change

Total Value Held $6.47 Million

Madhavan Balachandran Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2016	BUY Grant, award, or other acquisition	-	3,581 Added 13.42%	23,097 Common Stock
Apr 27 2016	SELL Bona fide gift	-	462 Reduced 2.31%	19,516 Common Stock
Apr 27 2016	SELL Payment of exercise price or tax liability	$75,237 $162.85 p/Share	462 Reduced 2.26%	19,978 Common Stock
Mar 25 2016	SELL Bona fide gift	-	21,796 Reduced 51.61%	20,440 Common Stock
Mar 25 2016	SELL Payment of exercise price or tax liability	$3,549,674 $149.24 p/Share	23,785 Reduced 36.03%	42,236 Common Stock
Mar 02 2016	BUY Grant, award, or other acquisition	-	45,268 Added 40.84%	65,570 Common Stock
Jan 31 2016	SELL Payment of exercise price or tax liability	$87,056 $152.73 p/Share	570 Reduced 2.44%	22,783 Common Stock
Jan 31 2016	SELL Bona fide gift	-	2,727 Reduced 11.84%	20,302 Common Stock
Jan 28 2016	SELL Payment of exercise price or tax liability	$139,185 $150.47 p/Share	925 Reduced 3.81%	23,353 Common Stock
Jul 31 2015	SELL Bona fide gift	-	4,438 Reduced 15.45%	24,278 Common Stock
Jul 31 2015	SELL Payment of exercise price or tax liability	$831,838 $171.69 p/Share	4,845 Reduced 14.44%	28,716 Common Stock
May 07 2015	SELL Open market or private sale	$3,434,107 $157.89 p/Share	21,750 Reduced 39.44%	33,394 Common Stock
May 07 2015	BUY Exercise of conversion of derivative security	$1,230,180 $56.56 p/Share	21,750 Added 28.29%	55,144 Common Stock
Apr 27 2015	SELL Payment of exercise price or tax liability	$73,545 $167.91 p/Share	438 Reduced 1.28%	33,831 Common Stock
Apr 27 2015	SELL Bona fide gift	-	437 Reduced 1.29%	33,394 Common Stock
Apr 25 2015	SELL Bona fide gift	-	767 Reduced 2.19%	34,269 Common Stock
Apr 25 2015	SELL Payment of exercise price or tax liability	$128,115 $167.91 p/Share	763 Reduced 2.13%	35,036 Common Stock
Mar 27 2015	SELL Bona fide gift	-	7,614 Reduced 17.54%	35,799 Common Stock
Mar 27 2015	SELL Payment of exercise price or tax liability	$1,334,331 $160.55 p/Share	8,311 Reduced 16.07%	43,413 Common Stock
Mar 04 2015	BUY Grant, award, or other acquisition	-	15,845 Added 23.58%	51,352 Common Stock
Jan 30 2015	BUY Grant, award, or other acquisition	-	3,677 Added 9.38%	35,507 Common Stock
Jan 28 2015	SELL Payment of exercise price or tax liability	$143,637 $158.89 p/Share	904 Reduced 2.63%	33,484 Common Stock
Jan 28 2015	SELL Bona fide gift	-	1,654 Reduced 4.94%	31,830 Common Stock
Jul 31 2014	SELL Payment of exercise price or tax liability	$618,588 $130.01 p/Share	4,758 Reduced 10.97%	38,602 Common Stock
Jul 31 2014	SELL Bona fide gift	-	4,358 Reduced 11.29%	34,244 Common Stock

Also insider at

CTLT

Catalent, Inc. Healthcare

Director

QURE

uniQure N.V. Healthcare

Director

REPL

Replimune Group, Inc. Healthcare

Director